Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.83 CNY
−2.28 B CNY
1.48 B CNY
374.63 M
About SHANGHAI JUNSHI BIOSCIENCES
Sector
Headquarters
Shanghai
Founded
2012
Website
ISIN
CNE1000041Z1
FIGI
BBG00QFRK2T8
Shanghai Junshi Biosciences Co., Ltd. engages in the discovery, development, clinical research, and commercialization of biopharmaceutical drugs. Its products include toripalimab injection, UBP1211, JS002, and UBP1213. The company was founded by Zhuo Bing Zhang and Ji Kuan Shan on December 27, 2012 and is headquartered in Shanghai, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 688180 is 30.88 CNY — it has increased by 0.52% in the past 24 hours. Watch SHANGHAI JUNSHI BIOSCIENCES stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange SHANGHAI JUNSHI BIOSCIENCES stocks are traded under the ticker 688180.
688180 stock has risen by 2.39% compared to the previous week, the month change is a −16.43% fall, over the last year SHANGHAI JUNSHI BIOSCIENCES has showed a −29.91% decrease.
We've gathered analysts' opinions on SHANGHAI JUNSHI BIOSCIENCES future price: according to them, 688180 price has a max estimate of 17.24 CNY and a min estimate of 10.94 CNY. Watch 688180 chart and read a more detailed SHANGHAI JUNSHI BIOSCIENCES stock forecast: see what analysts think of SHANGHAI JUNSHI BIOSCIENCES and suggest that you do with its stocks.
688180 reached its all-time high on Jul 15, 2020 with the price of 220.40 CNY, and its all-time low was 23.08 CNY and was reached on Sep 24, 2024. View more price dynamics on 688180 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
688180 stock is 2.87% volatile and has beta coefficient of 1.51. Track SHANGHAI JUNSHI BIOSCIENCES stock price on the chart and check out the list of the most volatile stocks — is SHANGHAI JUNSHI BIOSCIENCES there?
Today SHANGHAI JUNSHI BIOSCIENCES has the market capitalization of 30.41 B, it has decreased by −5.75% over the last week.
Yes, you can track SHANGHAI JUNSHI BIOSCIENCES financials in yearly and quarterly reports right on TradingView.
SHANGHAI JUNSHI BIOSCIENCES is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
688180 net income for the last quarter is −281.81 M CNY, while the quarter before that showed −361.93 M CNY of net income which accounts for 22.13% change. Track more SHANGHAI JUNSHI BIOSCIENCES financial stats to get the full picture.
No, 688180 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 2.57 K employees. See our rating of the largest employees — is SHANGHAI JUNSHI BIOSCIENCES on this list?
Like other stocks, 688180 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI JUNSHI BIOSCIENCES stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI JUNSHI BIOSCIENCES technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI JUNSHI BIOSCIENCES stock shows the sell signal. See more of SHANGHAI JUNSHI BIOSCIENCES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.